HOME >> MEDICINE >> NEWS
Small babies are more likely to be stressed adults

Small size at birth and slow growth in early childhood are associated with higher levels of psychological distress in adults, finds a study in this week's BMJ.

Cheung and colleagues studied the psychological health of over 9,000 British adults born in 1958 until age 42 years. Birth weight and growth in childhood was measured and factors such as father's social class and maternal smoking were accounted for.

They found that people who had a higher birth weight and a faster weight gain from birth to 7 years old had a lower level of psychological distress into middle age.

Previous studies could only demonstrate such a relation up to the age of 26 years, they conclude.


'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
3-Oct-2002


Page: 1

Related medicine news :

1. Small increases or blips in HIV levels do not signal mutations leading to drug-resistant HIV
2. Rices CNST awards Smalley/Curl funds for innovation
3. Small steps toward coverage
4. Small band of nurses plays key role keeping germ threats at bay
5. Small social circles tied to heart disease death in women
6. Small study shows SAMe may improve treatment of depression
7. South Floridas Small wins The Gerontological Society of Americas 2004 Margret M. Baltes Award
8. Smallpox vaccine can be diluted and still be effective, expanding supply if needed
9. Small, frequent doses of caffeine best strategy for staying awake
10. New study: Small, frequent doses of caffeine best strategy for staying awake
11. Small uterine fibroids may be linked with increased risk of miscarriage, early study results show

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Small babies are more likely stressed adults

(Date:11/18/2014)... Nov. 17, 2014 (HealthDay News) -- Hispanic women who,ve had ... a certain type of heart trouble than those who,ve had ... team of researchers led by Shivani Aggarwal of Wake Forest ... and older, from Chicago, Miami, New York City and San ... at least six children. A type of heart trouble ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... people on the verge of burning out are more likely ... suffering from so-called vital exhaustion -- a toxic combination of ... risk of developing heart disease, researchers report. "In our ... And I think, when that stress is left unchecked for ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... Sierra Leone who became infected with Ebola in his native country ... Martin Salia had arrived Saturday at Nebraska Medical Center in Omaha. ... hospital in Sierra Leone,s capital city of Freetown. Sierra Leone, ... been ravaged by the Ebola outbreak that began last spring and ...
(Date:11/18/2014)... Randy Dotinga HealthDay Reporter ... use smartphone apps that help them track how many calories ... people who used a popular one after their doctor recommended ... conclusively debunk the idea of using such apps as weight-loss ... and their level of motivation varied, the researchers noted, and ...
(Date:11/17/2014)... 17, 2014 Vernon Brewer, Founder and President ... last two weeks and saw firsthand the devastating holocaust that ... in Iraq and Syria. , “‘Holocaust’ is not a term ... killed or driven thousands of Christians and members of other ... situation is desperate. As ISIS expands, they continue to ...
Breaking Medicine News(10 mins):Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 2Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 3
(Date:11/18/2014)... Tocagen Inc. today announced that ... free survival at six months for recurrent high grade ... FC, compared to published benchmarks. HGG includes glioblastoma, the ... The data were delivered in an oral presentation at the ... of the Society for Neuro-Oncology (SNO) by Tim ...
(Date:11/17/2014)... CHARLOTTESVILLE, Va. , Nov. 17, 2014 HemoShear ... present at the 6th annual Partnering for Cures ... New York City . Marshall Summar , MD, ... Brian Wamhoff , PhD, Vice President of R&D and Co-founder ... of new rare disease treatments in less time and with ...
(Date:11/17/2014)... , Nov. 17, 2014   Wilson Therapeutics ... the start of a Phase 2 clinical study to ... WTX101 in Wilson Disease, a rare genetic disorder and ... to process copper. "We are delighted to ... patients as a next step in the development program ...
Breaking Medicine Technology:Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 2Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 4Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 5HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 2HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 3HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 4Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3
Cached News: